Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Testing & Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Magnetic Resonance Imaging (MRI)
1.2.3 Human Papillomavirus (HPV) Testing
1.2.4 Colonoscopy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Testing & Screening Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Lung Cancer
1.3.3 Blood Cancer
1.3.4 Bone Cancer
1.3.5 Gall Bladder Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Testing & Screening Market Perspective (2018-2033)
2.2 Cancer Testing & Screening Growth Trends by Region
2.2.1 Global Cancer Testing & Screening Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cancer Testing & Screening Historic Market Size by Region (2018-2023)
2.2.3 Cancer Testing & Screening Forecasted Market Size by Region (2024-2033)
2.3 Cancer Testing & Screening Market Dynamics
2.3.1 Cancer Testing & Screening Industry Trends
2.3.2 Cancer Testing & Screening Market Drivers
2.3.3 Cancer Testing & Screening Market Challenges
2.3.4 Cancer Testing & Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Testing & Screening Players by Revenue
3.1.1 Global Top Cancer Testing & Screening Players by Revenue (2018-2023)
3.1.2 Global Cancer Testing & Screening Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Testing & Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Testing & Screening Revenue
3.4 Global Cancer Testing & Screening Market Concentration Ratio
3.4.1 Global Cancer Testing & Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Testing & Screening Revenue in 2022
3.5 Cancer Testing & Screening Key Players Head office and Area Served
3.6 Key Players Cancer Testing & Screening Product Solution and Service
3.7 Date of Enter into Cancer Testing & Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Testing & Screening Breakdown Data by Type
4.1 Global Cancer Testing & Screening Historic Market Size by Type (2018-2023)
4.2 Global Cancer Testing & Screening Forecasted Market Size by Type (2024-2033)
5 Cancer Testing & Screening Breakdown Data by Application
5.1 Global Cancer Testing & Screening Historic Market Size by Application (2018-2023)
5.2 Global Cancer Testing & Screening Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cancer Testing & Screening Market Size (2018-2033)
6.2 North America Cancer Testing & Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cancer Testing & Screening Market Size by Country (2018-2023)
6.4 North America Cancer Testing & Screening Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Testing & Screening Market Size (2018-2033)
7.2 Europe Cancer Testing & Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cancer Testing & Screening Market Size by Country (2018-2023)
7.4 Europe Cancer Testing & Screening Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Testing & Screening Market Size (2018-2033)
8.2 Asia-Pacific Cancer Testing & Screening Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cancer Testing & Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific Cancer Testing & Screening Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Testing & Screening Market Size (2018-2033)
9.2 Latin America Cancer Testing & Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cancer Testing & Screening Market Size by Country (2018-2023)
9.4 Latin America Cancer Testing & Screening Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Testing & Screening Market Size (2018-2033)
10.2 Middle East & Africa Cancer Testing & Screening Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cancer Testing & Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa Cancer Testing & Screening Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dias Orin
11.1.1 Dias Orin Company Detail
11.1.2 Dias Orin Business Overview
11.1.3 Dias Orin Cancer Testing & Screening Introduction
11.1.4 Dias Orin Revenue in Cancer Testing & Screening Business (2018-2023)
11.1.5 Dias Orin Recent Development
11.2 Epigenetics
11.2.1 Epigenetics Company Detail
11.2.2 Epigenetics Business Overview
11.2.3 Epigenetics Cancer Testing & Screening Introduction
11.2.4 Epigenetics Revenue in Cancer Testing & Screening Business (2018-2023)
11.2.5 Epigenetics Recent Development
11.3 Techlab
11.3.1 Techlab Company Detail
11.3.2 Techlab Business Overview
11.3.3 Techlab Cancer Testing & Screening Introduction
11.3.4 Techlab Revenue in Cancer Testing & Screening Business (2018-2023)
11.3.5 Techlab Recent Development
11.4 Positive Bioscience
11.4.1 Positive Bioscience Company Detail
11.4.2 Positive Bioscience Business Overview
11.4.3 Positive Bioscience Cancer Testing & Screening Introduction
11.4.4 Positive Bioscience Revenue in Cancer Testing & Screening Business (2018-2023)
11.4.5 Positive Bioscience Recent Development
11.5 Genextropy
11.5.1 Genextropy Company Detail
11.5.2 Genextropy Business Overview
11.5.3 Genextropy Cancer Testing & Screening Introduction
11.5.4 Genextropy Revenue in Cancer Testing & Screening Business (2018-2023)
11.5.5 Genextropy Recent Development
11.6 M Genomics
11.6.1 M Genomics Company Detail
11.6.2 M Genomics Business Overview
11.6.3 M Genomics Cancer Testing & Screening Introduction
11.6.4 M Genomics Revenue in Cancer Testing & Screening Business (2018-2023)
11.6.5 M Genomics Recent Development
11.7 20/20 GeneSystems
11.7.1 20/20 GeneSystems Company Detail
11.7.2 20/20 GeneSystems Business Overview
11.7.3 20/20 GeneSystems Cancer Testing & Screening Introduction
11.7.4 20/20 GeneSystems Revenue in Cancer Testing & Screening Business (2018-2023)
11.7.5 20/20 GeneSystems Recent Development
11.8 AB SCIEX
11.8.1 AB SCIEX Company Detail
11.8.2 AB SCIEX Business Overview
11.8.3 AB SCIEX Cancer Testing & Screening Introduction
11.8.4 AB SCIEX Revenue in Cancer Testing & Screening Business (2018-2023)
11.8.5 AB SCIEX Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Detail
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Cancer Testing & Screening Introduction
11.9.4 Abbott Laboratories Revenue in Cancer Testing & Screening Business (2018-2023)
11.9.5 Abbott Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Testing & Screening Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Magnetic Resonance Imaging (MRI)
Table 3. Key Players of Human Papillomavirus (HPV) Testing
Table 4. Key Players of Colonoscopy
Table 5. Key Players of Others
Table 6. Global Cancer Testing & Screening Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cancer Testing & Screening Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Cancer Testing & Screening Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Cancer Testing & Screening Market Share by Region (2018-2023)
Table 10. Global Cancer Testing & Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Cancer Testing & Screening Market Share by Region (2024-2033)
Table 12. Cancer Testing & Screening Market Trends
Table 13. Cancer Testing & Screening Market Drivers
Table 14. Cancer Testing & Screening Market Challenges
Table 15. Cancer Testing & Screening Market Restraints
Table 16. Global Cancer Testing & Screening Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Cancer Testing & Screening Market Share by Players (2018-2023)
Table 18. Global Top Cancer Testing & Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Testing & Screening as of 2022)
Table 19. Ranking of Global Top Cancer Testing & Screening Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cancer Testing & Screening Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Testing & Screening Product Solution and Service
Table 23. Date of Enter into Cancer Testing & Screening Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Testing & Screening Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Cancer Testing & Screening Revenue Market Share by Type (2018-2023)
Table 27. Global Cancer Testing & Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Cancer Testing & Screening Revenue Market Share by Type (2024-2033)
Table 29. Global Cancer Testing & Screening Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Cancer Testing & Screening Revenue Market Share by Application (2018-2023)
Table 31. Global Cancer Testing & Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Cancer Testing & Screening Revenue Market Share by Application (2024-2033)
Table 33. North America Cancer Testing & Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Cancer Testing & Screening Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Cancer Testing & Screening Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Cancer Testing & Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Cancer Testing & Screening Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Cancer Testing & Screening Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Cancer Testing & Screening Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Cancer Testing & Screening Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Cancer Testing & Screening Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Cancer Testing & Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Cancer Testing & Screening Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cancer Testing & Screening Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Cancer Testing & Screening Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Cancer Testing & Screening Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Cancer Testing & Screening Market Size by Country (2024-2033) & (US$ Million)
Table 48. Dias Orin Company Detail
Table 49. Dias Orin Business Overview
Table 50. Dias Orin Cancer Testing & Screening Product
Table 51. Dias Orin Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 52. Dias Orin Recent Development
Table 53. Epigenetics Company Detail
Table 54. Epigenetics Business Overview
Table 55. Epigenetics Cancer Testing & Screening Product
Table 56. Epigenetics Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 57. Epigenetics Recent Development
Table 58. Techlab Company Detail
Table 59. Techlab Business Overview
Table 60. Techlab Cancer Testing & Screening Product
Table 61. Techlab Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 62. Techlab Recent Development
Table 63. Positive Bioscience Company Detail
Table 64. Positive Bioscience Business Overview
Table 65. Positive Bioscience Cancer Testing & Screening Product
Table 66. Positive Bioscience Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 67. Positive Bioscience Recent Development
Table 68. Genextropy Company Detail
Table 69. Genextropy Business Overview
Table 70. Genextropy Cancer Testing & Screening Product
Table 71. Genextropy Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 72. Genextropy Recent Development
Table 73. M Genomics Company Detail
Table 74. M Genomics Business Overview
Table 75. M Genomics Cancer Testing & Screening Product
Table 76. M Genomics Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 77. M Genomics Recent Development
Table 78. 20/20 GeneSystems Company Detail
Table 79. 20/20 GeneSystems Business Overview
Table 80. 20/20 GeneSystems Cancer Testing & Screening Product
Table 81. 20/20 GeneSystems Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 82. 20/20 GeneSystems Recent Development
Table 83. AB SCIEX Company Detail
Table 84. AB SCIEX Business Overview
Table 85. AB SCIEX Cancer Testing & Screening Product
Table 86. AB SCIEX Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 87. AB SCIEX Recent Development
Table 88. Abbott Laboratories Company Detail
Table 89. Abbott Laboratories Business Overview
Table 90. Abbott Laboratories Cancer Testing & Screening Product
Table 91. Abbott Laboratories Revenue in Cancer Testing & Screening Business (2018-2023) & (US$ Million)
Table 92. Abbott Laboratories Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Testing & Screening Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cancer Testing & Screening Market Share by Type: 2022 VS 2033
Figure 3. Magnetic Resonance Imaging (MRI) Features
Figure 4. Human Papillomavirus (HPV) Testing Features
Figure 5. Colonoscopy Features
Figure 6. Others Features
Figure 7. Global Cancer Testing & Screening Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Cancer Testing & Screening Market Share by Application: 2022 VS 2033
Figure 9. Lung Cancer Case Studies
Figure 10. Blood Cancer Case Studies
Figure 11. Bone Cancer Case Studies
Figure 12. Gall Bladder Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Cancer Testing & Screening Report Years Considered
Figure 15. Global Cancer Testing & Screening Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Cancer Testing & Screening Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Cancer Testing & Screening Market Share by Region: 2022 VS 2033
Figure 18. Global Cancer Testing & Screening Market Share by Players in 2022
Figure 19. Global Top Cancer Testing & Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Testing & Screening as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Cancer Testing & Screening Revenue in 2022
Figure 21. North America Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Cancer Testing & Screening Market Share by Country (2018-2033)
Figure 23. United States Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Cancer Testing & Screening Market Share by Country (2018-2033)
Figure 27. Germany Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Cancer Testing & Screening Market Share by Region (2018-2033)
Figure 35. China Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Cancer Testing & Screening Market Share by Country (2018-2033)
Figure 43. Mexico Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Cancer Testing & Screening Market Share by Country (2018-2033)
Figure 47. Turkey Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Cancer Testing & Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Dias Orin Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 50. Epigenetics Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 51. Techlab Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 52. Positive Bioscience Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 53. Genextropy Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 54. M Genomics Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 55. 20/20 GeneSystems Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 56. AB SCIEX Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 57. Abbott Laboratories Revenue Growth Rate in Cancer Testing & Screening Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed